These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21138682)

  • 1. [gammadelta T cells stimulated by zoledronate kill osteosarcoma cells].
    Jiang H; Xu Q; Yang C; Cao ZG; Li ZX; Ye ZM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Dec; 26(12):1195-7. PubMed ID: 21138682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of zoledronate on the cytotoxicity of γδ T cells from PBMCs of osteosarcoma patients against osteosarcoma].
    Li Z; Tang J; Sun L; Ye Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jan; 29(1):6-9. PubMed ID: 23294710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Amplification of γδ T cells in PBMCs of healthy donors and osteosarcoma patients stimulated by zoledronate].
    Li ZX; Sun LL; Cheng RL; Sun ZW; Ye ZM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Aug; 28(8):822-4. PubMed ID: 22863589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trastuzumab enhanced the cytotoxicity of Vγ9Vδ2 T cells against zoledronate-sensitized osteosarcoma cells.
    Liu M; Sun LL; Li YJ; Li HY; Zhang J; Li BH; Ye ZM
    Int Immunopharmacol; 2015 Sep; 28(1):160-7. PubMed ID: 26071219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic effects of gammadelta T cells expanded ex vivo by a third generation bisphosphonate for cancer immunotherapy.
    Sato K; Kimura S; Segawa H; Yokota A; Matsumoto S; Kuroda J; Nogawa M; Yuasa T; Kiyono Y; Wada H; Maekawa T
    Int J Cancer; 2005 Aug; 116(1):94-9. PubMed ID: 15756684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of IL-18 on expansion of gammadelta T cells stimulated by zoledronate and IL-2.
    Li W; Kubo S; Okuda A; Yamamoto H; Ueda H; Tanaka T; Nakamura H; Yamanishi H; Terada N; Okamura H
    J Immunother; 2010 Apr; 33(3):287-96. PubMed ID: 20445349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.
    Kondo M; Sakuta K; Noguchi A; Ariyoshi N; Sato K; Sato S; Sato K; Hosoi A; Nakajima J; Yoshida Y; Shiraishi K; Nakagawa K; Kakimi K
    Cytotherapy; 2008; 10(8):842-56. PubMed ID: 19016372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoptive immunotherapy for advanced non-small cell lung cancer using zoledronate-expanded γδTcells: a phase I clinical study.
    Sakamoto M; Nakajima J; Murakawa T; Fukami T; Yoshida Y; Murayama T; Takamoto S; Matsushita H; Kakimi K
    J Immunother; 2011 Mar; 34(2):202-11. PubMed ID: 21304399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type I IFN-mediated enhancement of anti-leukemic cytotoxicity of gammadelta T cells expanded from peripheral blood cells by stimulation with zoledronate.
    Watanabe N; Narita M; Yokoyama A; Sekiguchi A; Saito A; Tochiki N; Furukawa T; Toba K; Aizawa Y; Takahashi M
    Cytotherapy; 2006; 8(2):118-29. PubMed ID: 16698685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isopentenyl pyrophosphate secreted from Zoledronate-stimulated myeloma cells, activates the chemotaxis of γδT cells.
    Ashihara E; Munaka T; Kimura S; Nakagawa S; Nakagawa Y; Kanai M; Hirai H; Abe H; Miida T; Yamato S; Shoji S; Maekawa T
    Biochem Biophys Res Commun; 2015 Aug; 463(4):650-5. PubMed ID: 26047704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteosarcoma cell line growth inhibition by zoledronate-stimulated effector cells.
    Muraro M; Mereuta OM; Carraro F; Madon E; Fagioli F
    Cell Immunol; 2007 Oct; 249(2):63-72. PubMed ID: 18163982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zoledronate-induced S phase arrest and apoptosis accompanied by DNA damage and activation of the ATM/Chk1/cdc25 pathway in human osteosarcoma cells.
    Iguchi T; Miyakawa Y; Saito K; Nakabayashi C; Nakanishi M; Saya H; Ikeda Y; Kizaki M
    Int J Oncol; 2007 Aug; 31(2):285-91. PubMed ID: 17611684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Potential of Ex Vivo Expanded γδ T Cells against Osteosarcoma Cells.
    Ko Y; Jeong YH; Lee JA
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zoledronate blocks geranylgeranylation not farnesylation to suppress human osteosarcoma U2OS cells metastasis by EMT via Rho A activation and FAK-inhibited JNK and p38 pathways.
    Cheng HL; Lin CW; Yang JS; Hsieh MJ; Yang SF; Lu KH
    Oncotarget; 2016 Mar; 7(9):9742-58. PubMed ID: 26848867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic human peripheral blood-derived γδT cells kill glioblastoma cell lines: implications for cell-based immunotherapy for patients with glioblastoma.
    Nakazawa T; Nakamura M; Park YS; Motoyama Y; Hironaka Y; Nishimura F; Nakagawa I; Yamada S; Matsuda R; Tamura K; Sugimoto T; Takeshima Y; Marutani A; Tsujimura T; Ouji N; Ouji Y; Yoshikawa M; Nakase H
    J Neurooncol; 2014 Jan; 116(1):31-9. PubMed ID: 24062140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interferon-γ enhances human γδ T cell-mediated osteosarcoma cell killing in vitro].
    Li Z; Tang J; Ye Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jan; 33(1):22-5. PubMed ID: 23353149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zoledronate sensitizes neuroblastoma-derived tumor-initiating cells to cytolysis mediated by human γδ T cells.
    Nishio N; Fujita M; Tanaka Y; Maki H; Zhang R; Hirosawa T; Demachi-Okamura A; Uemura Y; Taguchi O; Takahashi Y; Kojima S; Kuzushima K
    J Immunother; 2012 Oct; 35(8):598-606. PubMed ID: 22996365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of MAPK signal transduction pathway in killing tumor cells by Mtb-Ag activated gammadelta T cells].
    Hu JG; Hou YQ; Li BQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jan; 21(1):21-3. PubMed ID: 15629076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing adoptive cancer immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimulation.
    Nada MH; Wang H; Workalemahu G; Tanaka Y; Morita CT
    J Immunother Cancer; 2017; 5():9. PubMed ID: 28239463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization of human osteosarcoma cells to Vγ9Vδ2 T-cell-mediated cytotoxicity by zoledronate.
    Li Z; Peng H; Xu Q; Ye Z
    J Orthop Res; 2012 May; 30(5):824-30. PubMed ID: 22025284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.